Nacubactam Enhances Meropenem Activity Against Carbapenem-Resistant Klebsiella Pneumoniae Producing Klebsiella Pneumoniae Carbapenemases (KPC)

Antimicrobial Agents and Chemotherapy- United States

doi 10.1128/aac.00432-19

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society for Microbiology

Related search

IMP-Producing Carbapenem-Resistant Klebsiella Pneumoniae in the United States

Journal of Clinical Microbiology
Microbiology
2011English

Molecular Epidemiological Insights Into Colistin-Resistant and Carbapenemases-Producing Clinical Klebsiella Pneumoniae Isolates

Infection and Drug Resistance
Infectious DiseasesPharmacology
2019English

Screening for Klebsiella Pneumoniae Producing Carbapenemase (KPC) in Prato (Italy)

Microbiologia Medica
2014Italian

Detection of KPC and Oxa-48 Gene in Clinical Isolates of Carbapenem Resistant Klebsiella Pneumoniae

2019English

In Vitro Activity of Carbapenems Alone and in Combination With Amikacin Against KPC-Producing Klebsiella Pneumoniae

Journal of Clinical Medicine Research
2011English

Meropenem Heteroresistance in Clinical Isolates of OXA-48-producing Klebsiella Pneumoniae

Diagnostic Microbiology and Infectious Disease
MedicineInfectious DiseasesMicrobiology
2019English

Detection of Carbapenem-Resistant Escherichia Coli and Klebsiella Pneumoniae Producing NDM-1 in Lebanon

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2012English

Outbreak of Imipenemase-1-Producing Carbapenem-Resistant Klebsiella Pneumoniae in an Intensive Care Unit

The Korean Journal of Critical Care Medicine
2017English

Author Correction: Rapid Susceptibility Profiling of Carbapenem-Resistant Klebsiella Pneumoniae

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy